Tag: Cancer: Leukemia
Zelboraf Approved for Use in Erdheim-Chester Disease
Kinase inhibitor (vemurafenib) for use in patients with BRAF V600 mutation
Leukemia Patients Who Survive Severe GVHD Often Fare Worse
Those who develop severe acute graft-versus-host after stem cell transplant have higher mortality
Immune Status Tied to Outcomes in Third-Gen CAR T-Cell Therapy
In leukemia/lymphoma, after treatment CD19-targeting chimeric antigen receptor T-cell therapy
FDA Approves First Gene Therapy in the United States
Kymriah approved for patients up to 25 years of age with refractory or relapsed B-cell precursor ALL
FDA Approves New Treatment for Acute Lymphoblastic Leukemia
For patients with relapsed or refractory B-cell ALL who have received one or two prior treatments
FDA Approves New Treatment for Acute Myeloid Leukemia
Vyxeos combines two previously approved drugs -- daunorubicin and cytarabine
FDA Approves Idhifa for Some With Acute Myeloid Leukemia
For adults with relapsed or refractory AML who have an IDH2 genetic mutation
FDA Approves Imbruvica to Treat Chronic Graft Versus Host Disease
Drug sanctioned for patients with cGVHD who do not respond to other forms of therapy
Potential First U.S. Gene Therapy Now Under FDA Review
Tisagenlecleucel could be a one-time treatment for children and young adults with advanced leukemia
Longer Survival for Midostaurin + Chemotherapy in AML With FLT3
Prolonged overall, event-free survival for patients with acute myeloid leukemia, FLT3 mutation
